Novartis

4 independently sourced, verified news trends involving Novartis.

Coverage evidence

This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Jul 6, 2026 through Oct 28, 2026.

Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.

◼ Archived Business 🔮 holds ✗

Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran fail

6 sources 6 articles v 4 9d ago

◼ Archived Business 🔮 holds ✗

Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager

5 sources 5 articles v 3 34d ago

◼ Archived Business 🔮 holds ✗

Novartis’ TREM2 drug fails Phase 2 ALS trial

6 sources 6 articles v 4 50d ago

◼ Archived Business 🔮 holds ✗

Novartis to Buy Myricx Bio for Up to $1.5 Billion

Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.

7 sources 7 articles v 5 122d ago